Background
We have previously shown the importance of mgrA and sarA in controlling autolysis of Staphylococcus aureus, with MgrA and SarA both being negative regulators of murein hydrolases.
Methods
In this study, we analyzed the effects of mgrA and sarA on antibiotic-mediated lysis in vitro, and on the responses to cell wall-active antibiotic therapy in an experimental endocarditis model using two representative MRSA strains: laboratory strain COL and community-acquired clinical isolate, MW2.
Results
We found that mgrA and sarA independently down-regulated sarV (a marker for autolysis), although the alteration in sarV expression did not correlate directly with the autolysis profiles of single mgrA and sarA mutants. Importantly, the mgrA/sarA double mutants of both strains were more autolytic in vitro as compared with the single mutants. In vivo, we demonstrated that, despite equivalent intrinsic virulence between the parents and their isogenic mgrA/sarA double mutants in the endocarditis model, oxacillin and vancomycin treatment of the mgrA/sarA double mutants of MRSA strains COL and MW2 yielded significant reductions in vegetation bacterial densities vs. their respective parents.
Conclusions
These results suggest that down-regulation of mgrA/sarA in combination with cell wall-active antibiotics may represent a novel approach to treat MRSA infections.